Pembrolizumab (Pembro) + Carboplatin (carbo) + Paclitaxel (pacli) as First-Line (1L) Therapy in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 4 KEYNOTE-B10 Study
Carboplatin;Paclitaxel;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Pembrolizumab (Pembro) + Carboplatin (carbo) + Paclitaxel (pacli) as First-Line (1L) Therapy in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 4 KEYNOTE-B10 Study ### Output: Carboplatin;Paclitaxel;Pembrolizumab